NextGen Precision Health researchers uncover

<p>New research at the Roy Blunt NextGen Precision Health Building has discovered a potential treatment for an underlying cause of cardiovascular disease in people with Type 2 diabetes.</p>

Related Keywords

United States ,American ,Americans ,James Smith ,Jameso Davis ,Larissa Ferreira Santos ,Francisco Ramirez Perez ,Katherine Burr ,Neil Mcmillan ,Luis Martinez Lemus ,Andrew Wheeler ,Camila Manrique Acevedo ,Shawn Bender ,Marc Augenreich ,Jaume Padilla ,Christopher Foote ,Thaysa Ghiarone ,Morgan Williams ,Mariana Morales Quinones ,Annayya Aroor ,Juan Gonzalez Vallejo ,University Of Missouri School Medicine ,Mu Health Care Weight Management Center ,University Of Missouri ,Roy Blunt Nextgen Precision Health ,College Of Veterinary Medicine ,Nextgen Precision Health ,Method Of Research ,School Of Medicine ,Missouri School ,American Journal ,Gavin Power ,Exercise Physiology ,Care Weight Management Center ,Veterinary Medicine ,Nextgen Precision ,Neuraminidase Inhibition ,Improve Glycocalyx Volume ,Ameliorate Cardiovascular Diseases ,Pathologies Associated ,Glycocalyx Damage ,